The clinical relevance of fetal nuchal translucency
✍ Scribed by E. Bäz; K. Hecher; B.-J. Hackelöer
- Publisher
- Springer
- Year
- 1999
- Tongue
- German
- Weight
- 514 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0017-5994
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In Sardinia, fetal karyotyping for couples at risk for -thalassaemia is offered only to women \_35 years and for specific risk of chromosomopathies. This policy is not easily accepted by the couples who insistently request additional karyotyping. In order to select those at highest risk of chromosom
We report a fetus with spinal muscular atrophy type I, who presented with an increased nuchal translucency at 13 weeks' gestation. A review of the literature reveals additional cases of spinal muscular atrophy type I associated with increased nuchal translucency and suggests increased nuchal translu
The aim of this screening study was to evaluate first-trimester screening for chromosomal defects by fetal nuchal translucency thickness at 10-14 weeks of gestation in four Fetal Medicine Units in Greece. Estimates of the risk for trisomy 21 were calculated taking into account fetal nuchal transluce
Nuchal translucency (NT) thickness measurement has been recently proposed as a part of routine ultrasound scanning during the late first trimester of pregnancy, for the early screening of chromosomal abnormalities. Manual determination of NT is currently performed using electronic calipers placed by
The aim of this study was to determine the value of nuchal translucency (NT) measurement for the detection of aneuploidies and other malformations in a low-risk population. In total, 4233 women who booked in our hospital for delivery were examined between the tenth and 13th week of gestation. Of the